Recently, the throughput of single-cell RNA-sequencing (transcriptomics) and genomics technologies has increased more than a 1000-fold. This increase has powered new analyses: Whereas traditional analysis of bulk tissue averages all differences between the diverse cells comprising such samples, single-cell analysis characterizes each individual cell and thus has enabled the discovery and classification of previously unknown cell states. Yet, the nucleic-acidbased technologies are effectively blind to an important group of biological regulators: proteins. Fortunately, emerging mass-spectrometry (MS) technologies that identify and quantify proteins promise to deliver similar gains to single-cell protein analysis. These proteomic technologies will enable high-throughput investigation of key biological questions, such as signaling mechanisms based on protein binding, modifications, and degradation, that have long remained elusive.
The abundance and activity of many proteins are regulated by degradation and posttranslational modifications (PTMs) that cannot be inferred from genomic and transcriptomic measurements. Moreover, genomic and transcriptomic sequencing cannot report directly on protein-protein interactions and protein localization, which are critical for numerous signaling pathways (13). The extracellular matrix surrounding each cell is composed of proteins whose chemical and physical properties, such as stiffness, can also play vital roles in regulating cellular behavior, including proliferation, migration, metastasis, and aging (4). Yet, current single-cell sequencing tools provide little information about the protein composition and biological roles of the extracellular matrix (35). Thus, methodologies are needed that can directly analyze a broad repertoire of intracellular, membrane-bound, and extracellular proteins at the single-cell level.
Single-cell protein analysis has a long history, but the conventional technologies have relatively limited capabilities (6, 7). Most proteomics methods, such as mass cytometry, cellular indexing of transcriptomes and epitopes by sequencing, RNA expression and protein sequencing, and CO-Detection by indEXing, rely on antibodies to detect select protein epitopes and can analyze only a few dozen proteins per cell (6) (see the figure). However, many antibodies have low specificity for their targets, which results in nonspecific protein detection. Indeed, fewer than a third of more than a thousand antibodies tested in multiple laboratories bind specifically to their cognate targets (6). As a result, $800 million is wasted worldwide annually on purchasing nonspecific antibodies and even more on experiments following up flawed hypotheses based on these nonspecific antibodies (8). Although some highly specific and well-validated antibodies can be useful to analyze a few proteins across many cells, the low specificity and limited throughput of the current generation of single-cell protein analytical methods pose challenges for understanding the interactions and functions of proteins at single-cell resolution.
These challenges are being addressed by emerging technologies for analyzing single cells by MS without the use of antibodies, such as Single Cell ProtEomics by MS (SCoPE-MS) and its second generation, SCoPE2. These methods allow the quantification of thousands of proteins across hundreds of single-cell samples (9, 10) (see the figure). A key driver of this progress was the development of multiplexed experimental designs in which proteins from single cells and from the total cell lysate of a small group of cells (called carrier proteins) are barcoded and then combined (9, 10). With this design, the carrier proteins reduce the loss of proteins from single cells adhering to equipment surfaces while simultaneously enhancing peptide identification.
Other key drivers of progress include methods for clean and automated sample preparation, for which there is preliminary evidence (11), as well as rigorous computational approaches that incorporate additional peptide features, such as retention time, to determine peptide sequences from limited sample quantities (12). Further technological developments can increase the accuracy of quantification and numbers of analyzed cells by 100- to 1000-fold while affording quantification of protein modifications at single-cell resolution (7). For example, the carrier protein approach (9) can be extended to quantify PTMs by using a carrier composed of peptides with PTMs while avoiding the need to enrich modified proteins from single cells and, thus, enrichment-associated protein losses.
Although current methods can quantify proteins present at 50,000 copies per cell (which is the median protein abundance in a typical human cell), increased efficiency of peptide delivery to MS analyzers, e.g., by increasing the time over which peptide ions (proteins are fragmented into peptides and ionized in MS analysis) are sampled (7, 13), will increase sensitivity to proteins present at only 1000 copies per cell. In general, the emerging technologies offer a trade-off between quantifying low-abundance proteins with increased accuracy or quantifying more proteins. This trade-off can be mitigated by simultaneously sampling multiple peptides (7). Over the next few years, improvements in sample preparation, peptide separation and ionization, and instrumentation are likely to afford quantification of more than 5000 proteins across thousands of single cells, while targeted approaches are poised to enable analysis of even low-abundance proteins of interest (7).
MS methods have the potential to measure not merely the abundance and PTMs of proteins in single cells, but also their complexes and subcellular localization. When proteins form a complex, polypeptide chains from different proteins can get close enough to be cross-linked by small molecules. Because only proteins in the complex are likely to be cross-linked, the abundance of such peptides can report directly on complex formation and composition. Some cross-linked peptide pairs are observed only with specific complex conformations, and thus these pairs can be useful in distinguishing active and inactive complexes. Furthermore, if a protein complex is close to organelles, targeted MS analysis of cross-linked peptides between the complex and organelle-specific proteins may report on the subcellular localization. Such analysis has not yet been applied to single-cell MS, but is likely to be feasible.
Realizing these exciting prospects requires concerted effort and community standards devoted to ensuring that hype does not overshadow scientific rigor. For example, systematic artifacts, such as contaminant proteins introduced to single-cell samples during their preparation or chromatographic separation, may result in reproducible measurements. Despite their reproducibility, such measurements do not reflect protein abundances in single cells. If reproducibility is misinterpreted as accuracy, the resulting errors may erode the credibility of this emerging field.
Single-cell proteomics will find many applications in biomedical research. Some applications, such as classifying cell states and cell types, overlap with those of single-cell RNA sequencing. Other applications can only be achieved by measuring proteins. For example, the development of cells for regenerative therapies through the rational engineering of directed differentiation may benefit from single-cell proteomics. Although there has been much progress in developing directed differentiation protocols for certain cell types, these efforts tend to rely on trial-and-error approaches (14). Many of the resulting protocols remain relatively inefficient: Only a fraction of the cells differentiate into the desired cell type, and such cells may not fully recapitulate the desired physiological phenotypes (14).
Traditional methods identify and quantify a limited number of proteins based on antibodies barcoded with DNA sequences, fluorophores, or transition metals. Emerging single-cell mass-spectrometry (MS) methods will allow high-throughput analysis of proteins and their posttranslational modifications, interactions, and degradation.
Next-generation single-cell proteomics analysis offers an alternative to this trial-and-error approach. If the signaling events (usually mediated by protein interactions and PTMs) that guide cell differentiation during normal development can be identified, it should be possible to recapitulate such signaling in induced pluripotent stem cells. This would require identifying the signaling processes that lead to the desired cell types and then simulating them by using agonists and/or antagonists. Whereas single-cell RNA sequencing can identify the cells of interest, the amounts of messenger RNA are poor surrogates for the signaling activities mediated by protein modifications, such as phosphorylation or protein cleavage (2, 15). Single-cell proteomics could provide a robust means to characterize such signaling dynamics.
Another potential application is the identification of the sets of molecular interactions leading from a genotype or a stimulus to a phenotype of interest. This goal presents a substantial challenge in part because interacting molecules within a pathway are rarely measured across a large range of phenotypic states to constrain cellular network models. This limitation is particularly evident for proteins and their PTMs (13). Yet, proteins are key regulators in cells; models that ignore them cannot capture molecular mechanisms involving protein interactions. For example, the absence of direct protein measurements compromises the ability to study signaling networks because most of the key regulatory variables are missing from the data. Currently, when proteins and their PTMs are measured in bulk tissues, they have been analyzed in a few tens to a few hundreds of samples (2, 3). Analyzing so few samples tends to require assumptions about the specific sets of interactions and functional dependencies that occur between interacting proteins and molecules. Such assumptions fundamentally underpin the inferred biological mechanisms and undermine their validity (3).
Next-generation single-cell protein analytical technologies will reduce these assumptions and thus increase the validity of inferred mechanisms. If proteins, RNAs, DNA, and metabolites are measured across tens of thousands of individual cells, it may be possible to identify direct molecular interactions without the need to make assumptions about basic aspects of the pathway. Next-generation single-cell analysis is poised to generate just this type of data, which should underpin systems-level understanding of intracellular and extracellular regulatory mechanisms.
Single-cell proteomics may also have clinical applications. Protein measurements from limited clinical samples are attractive because they afford direct measurements of deregulated signaling pathways that drive disease. Furthermore, measuring protein concentrations allows the development of assays to test therapies that induce protein degradation, which are among the most rapidly growing therapeutic modalities (15). Additionally, protein assays may be more robust than RNA-sequencing assays because protein concentrations are less noisy and proteins degrade more slowly than RNAs. Moreover, the cost of protein analysis will decrease proportionately with increased multiplexing (7, 11).
The latest generation of nucleic acidbased single-cell analytical methods has opened the door to describing the varied and complex constellation of cell states that exist within tissue. The next generation of proteomics-based methods will complement current methods while shifting the emphasis from description toward functional characterization of these cell states.
Acknowledgments: N.S. is an inventor on patent application 16/251,039. N.S. is supported by a New Innovator Award from the National Institute of General Medical Sciences (award no. DP2GM123497).
View post:
Unpicking the proteome in single cells - Science Magazine
- 10. The Promise of Induced Pluripotent Stem Cells (iPSCs ... [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- What are induced pluripotent stem cells? [Stem Cell ... [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 6 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 2 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 5 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 3 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 4 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- Embryonic and induced pluripotent stem cells Part 1 - Video [Last Updated On: May 5th, 2015] [Originally Added On: May 5th, 2015]
- piggyBac transposition reprograms fibroblasts to induced ... [Last Updated On: May 8th, 2015] [Originally Added On: May 8th, 2015]
- Induced Pluripotent Stem Cells (IPSCs) - HowStuffWorks [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- Pluripotency of Induced Pluripotent Stem Cells [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- Induced stem cells - Wikipedia, the free encyclopedia [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- Induced Pluripotent Stem Cells (iPS) | UCLA Broad Stem ... [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- iPS cells and reprogramming: turn any cell of the body ... [Last Updated On: June 2nd, 2015] [Originally Added On: June 2nd, 2015]
- induced pluripotent stem cells - RCN Corporation [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Generating Mice from Induced Pluripotent Stem Cells | Protocol [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Stem Cell Key Terms | California's Stem Cell Agency [Last Updated On: July 31st, 2015] [Originally Added On: July 31st, 2015]
- Cell potency - Wikipedia, the free encyclopedia [Last Updated On: July 31st, 2015] [Originally Added On: July 31st, 2015]
- Induced pluripotent stem cell therapy - Wikipedia, the ... [Last Updated On: August 3rd, 2015] [Originally Added On: August 3rd, 2015]
- Glossary [Stem Cell Information] [Last Updated On: August 15th, 2015] [Originally Added On: August 15th, 2015]
- STEMCELL Technologies Inc. Enters a Licensing Agreement ... [Last Updated On: August 29th, 2015] [Originally Added On: August 29th, 2015]
- Pluripotent Stem Cells 101 | Boston Children's Hospital [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- COMPLETE 2015-16 INDUCED PLURIPOTENT STEM CELL INDUSTRY REPORT [Last Updated On: October 20th, 2015] [Originally Added On: October 20th, 2015]
- Complete 2015-16 Induced Pluripotent Stem Cell Industry ... [Last Updated On: October 20th, 2015] [Originally Added On: October 20th, 2015]
- Derivation of Ethnically Diverse Human Induced Pluripotent ... [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Purest yet liver-like cells generated from induced ... [Last Updated On: August 30th, 2016] [Originally Added On: August 30th, 2016]
- World Induced Pluripotent Stem Cells Market - Opportunities ... [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
- Induced Pluripotent Stem Cells Market 2016: Hepatocytes ... [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
- The Promise of Induced Pluripotent Stem Cells (iPSCs ... [Last Updated On: September 23rd, 2016] [Originally Added On: September 23rd, 2016]
- Induced Pluripotent Stem Cells: 10 Years After the ... [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Induced Pluripotent Stem Cell Initiative | California's ... [Last Updated On: October 7th, 2016] [Originally Added On: October 7th, 2016]
- Stem Cell Basics VI. | stemcells.nih.gov [Last Updated On: October 12th, 2016] [Originally Added On: October 12th, 2016]
- Induced stem cells - Wikipedia [Last Updated On: October 18th, 2016] [Originally Added On: October 18th, 2016]
- Induced Pluripotent Stem Cells (iPS) - UCLA Broad Stem Cell [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Induced Pluripotent Stem Cells: A New Frontier for Stem ... [Last Updated On: October 27th, 2016] [Originally Added On: October 27th, 2016]
- Induced pluripotent stem cells and Parkinson's disease ... [Last Updated On: October 27th, 2016] [Originally Added On: October 27th, 2016]
- Generation of Induced Pluripotent Stem Cells with ... [Last Updated On: November 3rd, 2016] [Originally Added On: November 3rd, 2016]
- Generation of Neural Crest-Like Cells From Human ... [Last Updated On: November 14th, 2016] [Originally Added On: November 14th, 2016]
- Induced pluripotent stem-cell therapy - Wikipedia [Last Updated On: November 18th, 2016] [Originally Added On: November 18th, 2016]
- Generation of germline-competent induced pluripotent stem ... [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- Induced pluripotent stem cell models from X-linked ... [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Live Cell Imaging of Induced Pluripotent Stem Cell ... [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Induced Pluripotent Stem Cells - cellapplications.com [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Why Induced Pluripotent Stem Cells Are Vital for Glaucoma ... [Last Updated On: December 3rd, 2016] [Originally Added On: December 3rd, 2016]
- Stem Cell Glossary - stemcells.nih.gov [Last Updated On: December 5th, 2016] [Originally Added On: December 5th, 2016]
- Clinical potential of human-induced pluripotent stem cells ... [Last Updated On: December 5th, 2016] [Originally Added On: December 5th, 2016]
- Induced stem cells - Wikiversity [Last Updated On: December 17th, 2016] [Originally Added On: December 17th, 2016]
- Induced pluripotent stem cell Wikipedia StemCell Therapy [Last Updated On: December 17th, 2016] [Originally Added On: December 17th, 2016]
- Embryonic stem (ES) cells and induced pluripotent stem ... [Last Updated On: January 17th, 2017] [Originally Added On: January 17th, 2017]
- Induced Pluripotent Stem Cell Repository | California's ... [Last Updated On: January 23rd, 2017] [Originally Added On: January 23rd, 2017]
- induced pluripotent stem cells - eurostemcell.org [Last Updated On: January 27th, 2017] [Originally Added On: January 27th, 2017]
- When C9ORF72 Silences U2, Spliceosomes Can't Find What They ... - Alzforum [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- The Stem Cell Revolution - Seeking Alpha [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Evotec in neurology iPSC drug discovery collaboration with stem-cell specialist Censo - FierceBiotech [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Treating Asthma with Stem Cells | Technology Networks - Technology Networks [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Embryonic stem cells to be available for medical use in Japan by next March - The Japan Times [Last Updated On: July 5th, 2017] [Originally Added On: July 5th, 2017]
- This Study Could Help Extend the Human Lifespan - Futurism [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Grnenthal Group: Launch of the Project - Modelling Neuron-glia Networks Into a Drug Discovery Platform for Pain ... - PR Newswire (press release) [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- The Global Market for Induced Pluripotent Stem Cells (iPSCs) should reach $3.6 Billion in 2021, Increasing at a CAGR ... - Business Wire (press... [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- SBP Scientist Receives Prestigious WM Keck Foundation Grant - Newswise (press release) [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Is it time to start worrying about conscious human mini-brains? - PLoS Blogs (blog) [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- A New Epigenetic Barrier to Induced Pluripotent Stem Cells - WhatIsEpigenetics.com [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- What are induced pluripotent stem cells or iPS cells? - Stem ... [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- Stem Cell Glossary - Closer Look at Stem Cells [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- CRISPR Corrects Disease Mutation in Human Embryos - Genetic Engineering & Biotechnology News (blog) [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- World's 1st trial of drug developed from iPS cells to begin - Japan ... - Japan Today [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- ASU grad students' lab skills help earn funding for cutting-edge biomedical research - Arizona State University [Last Updated On: August 10th, 2017] [Originally Added On: August 10th, 2017]
- How Food Preservatives May Disrupt Human Hormones - Laboratory Equipment [Last Updated On: August 10th, 2017] [Originally Added On: August 10th, 2017]
- Dopaminergic neurons derived from iPSCs in non-human primate model - Phys.Org [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Artificial Blood Vessels Mimic Rare Accelerated Aging Disease - Duke Today [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Induced Pluripotent Stem Cells Market Demands, Trends, Growth ... - MilTech [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- induced pluripotent stem cell (iPS cell) | biology ... [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Induced Pluripotent Stem Cells: Global Markets Report 2017-2021 [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- MESO-BRAIN initiative receives 3.3million to replicate brain's neural networks through 3D nanoprinting - Cordis News [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Global Induced Pluripotent Stem Cells Market: HTF Market [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Induced Pluripotent Stem Cells in Global Effort to ... [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- How Do We Get Pluripotent Stem Cells? | Boston Children's ... [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Fertile offspring produced from sterile mice using iPS cells - Kyodo News Plus [Last Updated On: August 20th, 2017] [Originally Added On: August 20th, 2017]
- Brain Spheroids Hatch Mature Astrocytes | ALZFORUM - Alzforum [Last Updated On: August 20th, 2017] [Originally Added On: August 20th, 2017]
- Breakthrough in Gene Editing Comes as Scientists Correct Disease-Causing Mutation in Human Embryo - TrendinTech [Last Updated On: August 20th, 2017] [Originally Added On: August 20th, 2017]